- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 46.4M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.87B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.77B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $40.05M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $40.18M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $427.42M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $462.72M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.64B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.58B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $358.2M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $339.09M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.58B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.53B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 49.64M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $59.46M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $1.74M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $6.73M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $35.6M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.62 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.63 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $72.27M |
| Net Income | Q1 2025 · Mar 31, 2024 | $31.01M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $60.15M |